Avara Pharmaceutical Services, Inc.
- Kunal BahlChief Financial Officer · Web search
How we got $115.8M
Based on 221 employees on its 2025 401(k) filing.
Estimated value over time
▲ 26% since 2023Today's estimate scaled by the headcount reported each year and that year's prices. A trend, not a record of past sale values.
Employees over time
▲ 19% since 2023Show as table
| Year | Source | Employees | Est. revenue |
|---|---|---|---|
| 2023 | Form 5500 | 186 | $38.5M |
| 2024 | Form 5500 | 329 | $68.0M |
| 2025 | Form 5500 | 221 | $45.7M |
Participants are employees in the company's retirement plan at year end, from its Form 5500 filing with the Department of Labor. They usually run a little under total headcount (part-timers and new hires may not be eligible). Revenue and EBITDA apply this industry's revenue per employee and margin to each year's count.
What we know
Signs of a sale Unlikely to sell soon
- Headcount down 33% since 2024 (retirement plan filings)
From public records and the company's website, not a statement that it's for sale.
Compared with similar businesses nearby
| Business | Est. revenue | Distance |
|---|---|---|
| AVARA PHARMACEUTICAL SERVICES, INC. this business | $110.7M | — |
| IMMUNO-MYCOLOGICS, INC. Norman · 82 employees | $62.4M | 3.0 mi |
| Immy Norman | $1.1M | 3.0 mi |
| Avara Pharma Technologies Norman | $3.0M | 4.7 mi |
| SOLIDTECH ANIMAL HEALTH, INC. Newcastle · 10 employees | $6.6M | 6.8 mi |
| Purma Biologics, Llc. Oklahoma City | $2.0M | 11.5 mi |
| HOME CARE PHARMACY, INC. Oklahoma City · 1 employees | $1.2M | 14.5 mi |
The full calculation
Figures are shown toward the upper part of their range rather than at its middle.
Brought up to date: prices are 10% higher than in the benchmark's year, both included above.
| Estimated value = EBITDA × typical sale multiple | $115.8M |
| Multiple for this size and industry | 11.3× |
| Value range | $60.5M – $170.2M |
| Employees in its retirement plan (2025 Form 5500) | 221 |
| Industry revenue per employee | $207K |
| Revenue = employees × revenue per employee | $110.7M |
| EBITDA margin (industry, adjusted for size) | 9% |
| EBITDA = revenue × margin | $10.3M |
Uses the newest headcount we have: participants in the company's retirement plan from its Form 5500 filing with the Department of Labor. Plans can leave out part-timers and new hires, so the range leans higher than the estimate.
| Revenue range | $72.3M – $135.6M |
| EBITDA range | $6.7M – $12.6M |
| Industry (NAICS) | Pharmaceutical and medicine manufacturing (325410) |
EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.
Benchmarks: US Economic Census 2022, OK. These are statistical estimates, not reported financials. Listing details come from the company's Form 5500 retirement-plan filing. Full methodology
Public records
Matched to this business by name and address from public government data; a match can occasionally be wrong.
About Avara Pharmaceutical Services, Inc.
Avara Pharmaceutical Services, Inc. is a pharmaceutical and medicine manufacturing company in Norman, Oklahoma. It is owned by Antonio Ambrosio (Vice President and General Manager). Its estimated annual revenue is about $110.7M, with roughly $10.3M of EBITDA. It has about 221 employees. Its estimated business value is $115.8M (likely range $60.5M–$170.2M).
Common questions
- Who owns Avara Pharmaceutical Services, Inc.?
- Avara Pharmaceutical Services, Inc. is owned by Antonio Ambrosio (Vice President and General Manager), according to public sources such as the company's website or filings.
- How much revenue does Avara Pharmaceutical Services, Inc. make?
- SeeBITDA estimates Avara Pharmaceutical Services, Inc.'s annual revenue at about $110.7M (likely between $72.3M and $135.6M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
- What is Avara Pharmaceutical Services, Inc. worth?
- About $115.8M, roughly 11.3× its estimated EBITDA of $10.3M, typical for a pharmaceutical and medicine manufacturing company its size. Likely range: $60.5M–$170.2M.
- How many employees does Avara Pharmaceutical Services, Inc. have?
- About 221, from its 2025 retirement-plan filing.